AOD-9604 5mg

AOD-9604 is a modified C-terminal fragment of human growth hormone (HGH), specifically amino acids 176-191. Researchers have explored its potential metabolic effects, particularly concerning fat regulation, without directly impacting growth hormone receptor activity in various investigational studies. Unlike full-length growth hormone, AOD-9604 is designed to selectively target lipid metabolism.

This peptide has been of interest in research settings due to its reported capacity to influence fat metabolism. Researchers have investigated whether it could offer a novel approach to conditions associated with excess fat accumulation.

Mechanism of Action

The proposed mechanism of action for AOD-9604 in research models involves its interaction with beta-3 adrenergic receptors, leading to increased lipolysis (fat breakdown) and decreased lipogenesis (fat synthesis). It is thought to specifically mimic the fat-reducing effects of HGH without stimulating cell proliferation or affecting glucose homeostasis, thereby distinguishing its activity from the broader effects of intact HGH. This selective action is a key area of research.

Structure and Class

AOD-9604 is a synthetic analog of the 176-191 region of the human growth hormone polypeptide. It is classified as an HGH fragment and is distinguished by a tyrosine residue added at the N-terminus, which is believed to enhance its stability and metabolic activity in investigational settings. Its small size, compared to the full 191-amino acid growth hormone, allows for focused research into its specific metabolic pathways.

Primary Research Areas

Primary research areas for AOD-9604 include its potential applications in metabolic research, particularly in studies investigating fat loss and energy expenditure. Researchers are exploring its effects on adipose tissue, body composition, and other markers of metabolic health in various preclinical and clinical research models. The peptide is also studied for its potential in tissue repair and cartilage regeneration, although these areas are less extensively investigated than its metabolic effects.

Notable Peer-Reviewed Findings

Peer-reviewed research has indicated that AOD-9604 may induce fat loss in preclinical models, with studies reporting reductions in body weight and adipose tissue. For instance, some studies in obese animal models have shown a significant decrease in body fat without adverse effects on insulin sensitivity or glucose tolerance. Other research has explored its potential cartilage repair properties in animal models, suggesting a broader scope of action beyond just lipid metabolism, warranting further investigation.